NCI Company Profile (NASDAQ:NCIT)


NCI logoNCI, Inc. is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration. The Company helps its clients to navigate the range of cloud, Everything-as-a-Service (EaaS), capacity services and virtualization options available. The Company provides its customers the full lifecycle of cybersecurity services, including policy and planning, compliance, identity and access management, training, education, awareness and enterprise security operations.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: IT Services & Consulting
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NCIT
  • CUSIP: N/A
  • Web:
Average Prices:
  • 50 Day Moving Avg: $20.07
  • 200 Day Moving Avg: $16.90
  • 52 Week Range: $10.98 - $21.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 18.87
  • P/E Growth: 0.00
  • Net Margins: 2.53%
  • Return on Equity: 8.07%
  • Return on Assets: 5.69%
  • Current Ratio: 1.50%
  • Quick Ratio: 1.50%
  • Average Volume: 113,959 shs.
  • Beta: 1.01

Frequently Asked Questions for NCI (NASDAQ:NCIT)

What is NCI's stock symbol?

NCI trades on the NASDAQ under the ticker symbol "NCIT."

How were NCI's earnings last quarter?

NCI Inc (NASDAQ:NCIT) issued its quarterly earnings results on Wednesday, October, 26th. The company reported $0.24 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.23 by $0.01. The business had revenue of $79.80 million for the quarter, compared to analyst estimates of $79.28 million. NCI had a return on equity of 8.07% and a net margin of 2.53%. The company's revenue was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 earnings per share. View NCI's Earnings History.

Where is NCI's stock going? Where will NCI's stock price be in 2017?

4 brokers have issued 12-month target prices for NCI's shares. Their predictions range from $11.00 to $24.00. On average, they expect NCI's share price to reach $18.33 in the next year. View Analyst Ratings for NCI.

What are analysts saying about NCI stock?

Here are some recent quotes from research analysts about NCI stock:

  • 1. According to Zacks Investment Research, "NCI, Inc. is a leading provider of information technology services and solutions to U.S. federal government agencies. NCI's award-winning expertise encompasses areas critical to its customers' mission objectives including enterprise systems management, information assurance, network engineering, and systems development and integration. " (8/15/2017)
  • 2. Cowen and Company analysts commented, "NCIT offers an attractive risk/reward profile as its peer-low valuation (5.9x EV/EBITDA)." (4/10/2017)
  • 3. FBR & Co analysts commented, "We take a neutral perspective on NCI shares for the time being, although we are encouraged by the efforts that the company is taking to position itself for success in an evolving government IT landscape. CEO Paul Dillahay was appointed in October 2016, and we believe he is taking steps to increase NCI’s ability to capture new business. Given that we estimate that this company has a very strong recompete win rate, the base upon which the team can build appears fairly stable. That being said, we think that the company has outsized dependence on a few larger contracts —like the PEO Soldier contract that we estimate accounted for 16% of revenue in 2016—and there may be a near-term sentiment overhang on the stock related to the recently disclosed alleged embezzlement by the former controller. The company does have significant capabilities in agile software development, and we believe management’s approach is inspired; there could be an opportunity to become more constructive in the future, but for the time being, we think that remaining on the sidelines would be advisable." (4/4/2017)

Who are some of NCI's key competitors?

Who are NCI's key executives?

NCI's management team includes the folowing people:

  • Paul A. Dillahay, President, Chief Executive Officer, Director
  • Lucas J. Narel, Chief Financial Officer, Executive Vice President, Treasurer
  • Michele R. Cappello, Senior Vice President, General Counsel
  • Charles K. Narang CPA, Non-Executive Chairman of the Board
  • Cindy E Moran, Director
  • James P. Allen, Independent Director
  • Paul V. Lombardi, Independent Director
  • Austin J. Yerks III, Independent Director

How do I buy NCI stock?

Shares of NCI can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NCI's stock price today?

One share of NCI stock can currently be purchased for approximately $20.00.

MarketBeat Community Rating for NCI (NASDAQ NCIT)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  364 (Vote Underperform)
Total Votes:  620
MarketBeat's community ratings are surveys of what our community members think about NCI and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NCI (NASDAQ:NCIT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $18.33 (8.33% downside)
Consensus Price Target History for NCI (NASDAQ:NCIT)
Price Target History for NCI (NASDAQ:NCIT)
Analysts' Ratings History for NCI (NASDAQ:NCIT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/17/2017Cowen and CompanySet Price TargetBuy$24.00LowView Rating Details
7/6/2017Noble FinancialReiterated RatingHoldLowView Rating Details
7/3/2017SunTrust Banks, Inc.DowngradeBuy -> Hold$24.00 -> $20.00LowView Rating Details
4/4/2017FBR & CoReiterated RatingHold$11.00HighView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for NCI (NASDAQ:NCIT)
Earnings by Quarter for NCI (NASDAQ:NCIT)
Earnings History by Quarter for NCI (NASDAQ NCIT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017$0.21$0.25$76.55 million$78.75 millionViewListenView Earnings Details
10/26/2016Q316$0.23$0.24$79.28 million$79.80 millionViewListenView Earnings Details
7/27/2016Q216$0.23$0.23$85.10 million$81.90 millionViewListenView Earnings Details
4/27/2016Q116$0.21$0.24$83.52 million$83.70 millionViewListenView Earnings Details
2/10/2016Q415$0.21$0.26$81.69 million$84.00 millionViewListenView Earnings Details
10/28/2015Q315$0.20$0.23$84.64 million$82.31 millionViewListenView Earnings Details
7/29/2015Q2$0.19$0.22$83.56 million$86.00 millionViewListenView Earnings Details
4/29/2015Q115$0.15$0.18$199.40 million$81.00 millionViewListenView Earnings Details
2/11/2015Q4$0.17$0.18$75.70 million$74.00 millionViewListenView Earnings Details
10/29/2014Q314$0.15$0.17$74.10 million$75.60 millionViewListenView Earnings Details
7/30/2014Q214$0.14$0.18$78.04 million$77.80 millionViewListenView Earnings Details
4/30/2014Q114$0.14$0.16$77.59 million$89.10 millionViewListenView Earnings Details
2/12/2014Q413$0.10$0.16$70.18 million$79.90 millionViewListenView Earnings Details
10/29/2013Q313$0.10$0.11$72.94 million$77.90 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.10$0.14$78.64 million$82.90 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.08$0.15$81.92 million$91.50 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.11$0.15$89.28 million$89.70 millionViewListenView Earnings Details
11/7/2012Q312$0.07$0.14$85.06 million$88.50 millionViewN/AView Earnings Details
8/1/2012$0.07$0.11ViewN/AView Earnings Details
5/2/2012$0.09$0.12ViewN/AView Earnings Details
2/15/2012$0.13$0.15ViewN/AView Earnings Details
8/3/2011$0.36$0.28ViewN/AView Earnings Details
5/5/2011$0.44$0.41ViewN/AView Earnings Details
2/16/2011$0.45$0.50ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NCI (NASDAQ:NCIT)
2017 EPS Consensus Estimate: $0.98
2018 EPS Consensus Estimate: $1.06
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.22$0.22$0.22
Q2 20172$0.25$0.25$0.25
Q3 20172$0.25$0.26$0.26
Q4 20172$0.25$0.25$0.25
Q1 20182$0.24$0.26$0.25
Q2 20182$0.26$0.26$0.26
Q3 20182$0.27$0.28$0.28
Q4 20182$0.26$0.29$0.28
(Data provided by Zacks Investment Research)


Dividend History by Quarter for NCI (NASDAQ NCIT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for NCI (NASDAQ:NCIT)
Insider Ownership Percentage: 45.36%
Institutional Ownership Percentage: 38.58%
Insider Trades by Quarter for NCI (NASDAQ:NCIT)
Institutional Ownership by Quarter for NCI (NASDAQ:NCIT)
Insider Trades by Quarter for NCI (NASDAQ:NCIT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2016Brian J ClarkCEOBuy3,000$11.10$33,300.00View SEC Filing  
4/28/2016Charles K NarangDirectorSell21,200$15.05$319,060.00View SEC Filing  
4/27/2016Charles K NarangDirectorSell26,335$15.00$395,025.00View SEC Filing  
3/4/2016Charles K NarangDirectorSell11,130$15.00$166,950.00View SEC Filing  
2/29/2016Charles K NarangDirectorSell14,066$15.01$211,130.66View SEC Filing  
12/16/2015Charles K. NarangDirectorSell9,610$15.17$145,783.70View SEC Filing  
6/20/2014Dinesh BhugraMajor ShareholderSell3,500$10.00$35,000.00View SEC Filing  
6/19/2014Dinesh BhugraMajor ShareholderSell70,866$10.00$708,660.00View SEC Filing  
5/6/2014Dinesh Bhugramajor shareholderSell13,534$10.21$138,182.14View SEC Filing  
3/28/2013John E LawlerDirectorBuy1,000$4.94$4,940.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for NCI (NASDAQ:NCIT)
Latest Headlines for NCI (NASDAQ:NCIT)
Loading headlines, please wait.



NCI (NCIT) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.